-
SFDA issues Guideline on Management of Phase I Clinical Trial of Drugs (interim)To enhance the management of the Phase I clinical trial of drugs, effectively safeguard the rights, benefits and safety of trial subjects, and improve the research quality and management of the Phase2011/12/7
-
Abbott dismisses talk of pharma unit saleDec 5 (Reuters) - Abbott Laboratories has no intention of selling its soon-to-be-separated pharmaceuticals business to another drugmaker and any potential bidder would struggle to persuade management2011/12/6
-
Back pain, arthritis to dominate chronic pain market: studyDrugs for the treatment of chronic back pain and arthritis-related pain will continue to be the most lucrative segments of the market for chronic pain treatments up to 2020, according to new forecasts2011/12/6
-
Report shows Big Pharma's patent cliff in graphic detailFOR some years the big drugmakers have been dreading an approaching “patent cliff”—a slump in sales as the patents on their most popular pills expire or are struck down by legal challenges, with few2011/12/5
-
Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs SaysPfizer Inc. (PFE) and Merck & Co. (MRK) are among the top U.S. companies best placed to sell assets as investors push for spinoffs, according to Goldman Sachs Group Inc. (GS) Merck and Pfizer may2011/12/5
-
CEO: Roche would consider more money-back dealsRoche offered such a scheme inGermanyfor cancer drug Avastin * Could consider this for other countries, but depends on each one Dec 1 (Reuters) - Swiss drugmaker Roche Holding AG would consider o2011/12/5
-
Lipitor going generic, Pfizer making deals to keep consumersThe popular cholesterol-lowering drug Lipitor goes off-patent today. Manufacturer Pfizer planned ahead, making agreements with some insurers to keep covering the drug. The New York Times: Facing Ge2011/12/2
-
Taking sleep medication or drinking alcohol does not benefit people with insomniaReaching for that sleeping pill or drinking alcohol may not be the most effective way for people with insomnia to get better sleep at night in the long run, suggests a new study by Ryerson University2011/12/2
-
SFDA Commissioner Shao Mingli meets delegation led by Former U.S. Assistant to the President for National Security AffairsOn November 30, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA) met with the Advanced Medical Technology Association of America delegation headed by Samuel Berger, For2011/12/2
-
Pfizer backs its highest grosser LipitorBy Dr Ananya Mandal, MD Pfizer’s Lipitor, a blood cholesterol lowering drug, is a popular one the among general population. However now that a generic competition for the drug has arrived in the ma2011/12/1